{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-154103","form_type":"8-K","ticker":"MSFT","cik":"0000789019","company_name":"MICROSOFT CORP","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.374527+00:00","generated_at":"2026-05-18T11:27:02.588893+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Microsoft amends bylaws to add cure process for shareholder director nomination deficiencies","bullets":["Board amended Bylaws effective July 1, 2025 to implement a cure process for certain deficiencies in director nomination notices.","Company will notify shareholders of deficiencies and provide an opportunity to cure within the time period specified in the Bylaws.","Full text of amended Bylaws filed as Exhibit 3.2 to the Form 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-154103","json":"https://secwatch.observer/filing/0001193125-25-154103.json","markdown":"https://secwatch.observer/filing/0001193125-25-154103.md","text":"https://secwatch.observer/filing/0001193125-25-154103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/789019/000119312525154103/0001193125-25-154103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/789019/000119312525154103/d84624d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T11:27:02.588893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b77411be8641d3f98ce595f73cca96abe7d4ddc","claim":"MICROSOFT CORP: The Company's Bylaws were amended to implement a cure process for deficiencies in director nomination notices submitted by shareholders (effective 2025-07-01).","evidence_excerpt":"The Board of Directors of Microsoft Corporation (the “Company”) amended the Company’s Bylaws, effective July 1, 2025. The amendments implement a cure process for certain deficiencies in director nomination notices submitted by shareholders.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/789019/000119312525154103/0001193125-25-154103-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-07-01"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}